Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
China · Delayed Price · Currency is CNY 3.120
+0.140 (4.70%)
Aug 20, 2026, 3:04 PM CST
SHE:300111 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,016 | 7,891 | 4,171 | 3,913 | 3,651 | 3,527 | |
Market Cap Growth | -21.61% | 89.20% | 6.58% | 7.19% | 3.49% | -1.56% |
Enterprise Value | 3,653 | 7,513 | 3,677 | 3,475 | 3,534 | 3,456 |
Last Close Price | 3.12 | 6.13 | 3.24 | 3.04 | 3.26 | 3.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 532.83 | 179.93 | - | 66.04 |
Forward PE | - | 28.39 | 28.39 | 28.39 | 28.39 | 28.39 |
PS Ratio | 15.82 | 29.06 | 12.62 | 11.56 | 10.87 | 11.87 |
PB Ratio | 4.93 | 9.63 | 5.07 | 4.83 | 8.80 | 8.60 |
P/TBV Ratio | 6.34 | 12.37 | 6.53 | 6.24 | 15.28 | 13.06 |
P/FCF Ratio | - | - | 224.86 | - | - | 42.82 |
P/OCF Ratio | - | 1879.90 | 132.67 | 1363.56 | 151.11 | 35.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 14.39 | 27.67 | 11.13 | 10.27 | 10.52 | 11.63 |
EV/EBITDA Ratio | - | 2067.16 | 423.76 | 116.47 | 276.02 | 50.42 |
EV/EBIT Ratio | - | - | - | 271.76 | - | 69.89 |
EV/FCF Ratio | - | - | 198.26 | - | - | 41.95 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | - | 0.00 | 0.01 | 0.06 | 0.08 | 0.00 |
Debt / EBITDA Ratio | - | 0.21 | 0.61 | 1.54 | 2.43 | 0.01 |
Debt / FCF Ratio | - | - | 0.31 | - | - | 0.01 |
Net Debt / Equity Ratio | -0.61 | -0.61 | -0.68 | -1.03 | -0.48 | -0.50 |
Net Debt / EBITDA Ratio | -303.84 | -138.69 | -64.72 | -27.87 | -15.63 | -2.99 |
Net Debt / FCF Ratio | 12.48 | 90.68 | -30.28 | 112.00 | 11.12 | -2.49 |
Asset Turnover | 0.26 | 0.27 | 0.30 | 0.36 | 0.54 | 0.50 |
Inventory Turnover | 1.26 | 1.39 | 1.96 | 2.21 | 2.56 | 2.52 |
Quick Ratio | 5.18 | 4.88 | 4.73 | 2.40 | 2.10 | 2.73 |
Current Ratio | 6.71 | 6.23 | 5.79 | 2.75 | 2.81 | 3.23 |
Return on Equity (ROE) | -1.02% | -0.49% | 1.64% | 3.91% | 1.10% | 19.34% |
Return on Assets (ROA) | -0.85% | -0.73% | -0.45% | 0.86% | -0.29% | 5.17% |
Return on Invested Capital (ROIC) | -4.22% | -4.04% | -6.77% | 12.75% | -1.33% | 37.52% |
Return on Capital Employed (ROCE) | -1.60% | -1.40% | -0.90% | 1.50% | -0.60% | 10.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -0.24% | -0.06% | 0.19% | 0.56% | -0.03% | 1.51% |
FCF Yield | -1.00% | -0.07% | 0.45% | -0.19% | -0.49% | 2.33% |
Payout Ratio | - | - | 13.95% | 7.63% | - | - |
Buyback Yield / Dilution | 0.03% | 1.33% | -1.97% | -12.35% | -2.32% | 0.62% |